Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bicuspid Aortic Valve Registry (BAV)

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2015 by University of Michigan
Sponsor:
Information provided by (Responsible Party):
Dr. Bo Yang, University of Michigan
ClinicalTrials.gov Identifier:
NCT01756222
First received: December 19, 2012
Last updated: December 9, 2015
Last verified: December 2015

December 19, 2012
December 9, 2015
April 2010
December 2017   (final data collection date for primary outcome measure)
Characterizing patients with bicuspid aortic valve disease [ Time Frame: 30 years ] [ Designated as safety issue: No ]
Identifying patients with bicuspid aortic valve disease, assessing the effect of medical intervention.
Same as current
Complete list of historical versions of study NCT01756222 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Bicuspid Aortic Valve Registry
Bicuspid Aortic Valve and Ascending Aortic Aneurysm Registry
The purpose of this registry is to gather information on patients with bicuspid aortic valve disease.
The purpose of this registry is to gather information on patients with bicuspid aortic valve disease. The data collected in the registry will be used to assess patterns of aortic dilation, responses to medical therapy based on serial imaging and to assess for potential genetic markers of this disease
Observational [Patient Registry]
Observational Model: Case-Only
Time Perspective: Prospective
30 Years
Retention:   Samples With DNA
Description:
Blood
Non-Probability Sample
Primary clinic
Bicuspid Aortic Valve
Not Provided
Bicuspid Aortic Valve Disease Patients
Patients with the diagnosis of BAV disease.
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
500
December 2017
December 2017   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Any patient over the age of 18 who is able/willing to give informed consent with the diagnosis of bicuspid aortic valve disease, a family history of this disease or an ascending aortic aneurysm that is idiopathic can be included in the registry.

Exclusion Criteria:

  • Patients unable or unwilling to give informed consent.
Both
18 Years and older   (Adult, Senior)
Yes
Contact: Whitney Hornsby, PhD 734-2324779 whornsby@med.umich.edu
United States
 
NCT01756222
HUM00035836
Yes
Not Provided
Not Provided
Dr. Bo Yang, University of Michigan
University of Michigan
Not Provided
Principal Investigator: Bo Yang, MD University of Michigan
University of Michigan
December 2015

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP